Ping An Biomedical
PASW
4 hedge funds and large institutions have $31.4K invested in Ping An Biomedical in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
24% more capital invested
Capital invested by funds: $25.4K → $31.4K (+$6.03K)
0.92% more ownership
Funds ownership: 0.25% → 1.16% (+0.92%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$23.7K |
| 2 |
Jane Street
New York
|
+$11K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$6.94K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$11.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
XT
1
XTX Topco
George Town,
Cayman Islands
| $18K | +$23.7K | +113,348 | +491% |
|
|
2
Jane Street
New York
| $6.93K | +$11K | +52,518 | New |
|
|
TSS
3
Two Sigma Securities
New York
| $4.38K | +$6.94K | +33,223 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $2.14K | +$2.4K | +11,515 | +244% |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$11.5K | -22,886 | Closed |
|
PASW Hedge Fund Activity: Q1 2026 in Review
4 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Ping An Biomedical (PASW) for Q1 2026, worth a combined $31.4K — up 24% from $25.4K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PASW positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was XTX Topco, adding an estimated $23.7K. The largest seller was Citadel Advisors, exiting entirely with an estimated $11.5K sold.
- 4 institutional investors held Ping An Biomedical (PASW) as of Q1 2026, up from 3 in Q4 2025.
- Funds reported $31.4K of Ping An Biomedical stock for Q1 2026, up 24% quarter-over-quarter.
- 2 funds opened new Ping An Biomedical positions in Q1 2026 and 1 closed out, a net change of +1 holder.
- The largest Ping An Biomedical buyer in Q1 2026 was XTX Topco, an estimated $23.7K added.
- The largest Ping An Biomedical seller in Q1 2026 was Citadel Advisors, an estimated $11.5K sold.
Based on aggregated 13F filings for Q1 2026.